Shopping Cart
- Remove All
- Your shopping cart is currently empty
TB22 is a non-nucleoside inhibiTor of DOT1LR231Q wiTh anTicancer acTiviTy. IT inhibiTs The malignanT phenoType of lung cancer cells harboring The R231Q muTaTion via The MAPK/ERK signaling paThway, making iT useful for lung cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | TB22 is a non-nucleoside inhibiTor of DOT1LR231Q wiTh anTicancer acTiviTy. IT inhibiTs The malignanT phenoType of lung cancer cells harboring The R231Q muTaTion via The MAPK/ERK signaling paThway, making iT useful for lung cancer research. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.